How much revenue does Pfizer make?

Pfizer reported 22.81 billion INR in revenue for fiscal year 2025, up 4.0% from 21.93 billion INR in fiscal year 2024. In Q3 2026 revenue was 6.45 billion INR.

Where does Pfizer make most of its revenue?

India: 95% of revenue by region in fiscal year 2025, followed by outside of India (5%).

What companies are similar to Pfizer?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Wockhardt Limited (WOCKPHARMA.NS), Granules India Limited (GRANULES.NS), Caplin Point Laboratories Limited (CAPLIPOINT.NS), Eris Lifesciences Limited (ERIS.NS).

Pfizer Limited (PFIZER.NS) Stock

About Pfizer Limited

Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers therapy area and products, such as vaccines, injectables and anti-infectives, inflammation and immunology, and internal medicine for cardiovascular care, oncology, respiratory, multivitamins and multimineral, neuroscience, women's health, gastroenterology...

At a glance

Pfizer reported revenue of 22.81 billion INR for fiscal year 2025, up 4.0% from fiscal year 2024, and net income of 7.68 billion INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 6.45 billion INR, up 19.9% from a year before. India was its largest region in fiscal year 2025, with 95% of revenue.

Figures from company filings; latest fiscal year ended March 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.